Photo of Dr. Daniel R. Touchette

Daniel R. Touchette


Professor, Pharmacy Systems, Outcomes and Policy
Director, Center for Pharmacoepidemiology and Pharmacoeconomic Research
Director of Graduate Studies, MS CER Program, Pharmacy Systems, Outcomes and Policy

Contact

Building & Room:

Room 256, College of Pharmacy

Address:

833 South Wood Street, Chicago, IL, 60612

Office Phone:

(312) 355-3204

Fax:

(312) 996-2954

Email:

drtouche@uic.edu

CV Link:

Daniel R. Touchette

Related Sites:

About

Research Interests: Dr. Daniel Touchette is Professor in the Department of Pharmacy Systems, Outcomes, and Policy and is co-Director of the UIC Center for Pharmacoepidemiology and Pharmacoeconomics Research (CPR). Dr. Touchette received his BS in Pharmacy from the University of Manitoba, and his PharmD and Master of Economics degree from Wayne State University in Detroit. He also completed a fellowship in pharmacoeconomics and outcomes research at Wayne State. Dr. Touchette's research interests are in the broad areas of pharmacoeconomics and outcomes research. In particular he is interested in designing and evaluating clinical pharmacist and other healthcare practitioner activities, especially with regards to optimizing medication adherence and reducing the adverse effects of medicines.

Selected Publications

  • Tilton JJ, Edakkunnathu MG, Moran KM, Markel Vaysman A, DaPisa JL, Goen BM, Touchette D. Impact of a Medication Therapy Management Clinic on Glycosylated Hemoglobin, Blood Pressure, and Resource Utilization.. The Annals of pharmacotherapy. 2018;:1060028018794860. doi:10.1177/1060028018794860.

  • Kim K, Lee TA, Touchette D, DiDomenico RJ, Ardati AK, Walton SM. Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome.. Journal of managed care & specialty pharmacy. 2018;24(8):800-812. doi:10.18553/jmcp.2018.24.8.800.

  • Xing S, Kim S, Schumock GT, Touchette D, Calip GS, Leow AD, Lee TA. Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.. The primary care companion for CNS disorders. 2018;20(3). doi:10.4088/PCC.17m02220.

  • Zueger PM, Kumar VM, Harrington RL, Rigoni GC, Atwood A, DiDomenico RJ, Touchette D. Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States.. Pharmacotherapy. 2018;38(5):520-530. doi:10.1002/phar.2108.

  • Xing S, Calip GS, Leow AD, Kim S, Schumock GT, Touchette D, Lee TA. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.. Journal of diabetes and its complications. 2018;32(5):492-500. doi:10.1016/j.jdiacomp.2017.12.008.

  • Sharp L, Tilton JJ, Touchette D, Xia Y, Mihailescu D, Berbaum ML, Gerber BS. Community Health Workers Supporting Clinical Pharmacists in Diabetes Management: A Randomized Controlled Trial.. Pharmacotherapy. 2018;38(1):58-68. doi:10.1002/phar.2058.

  • Poloyac SM, Block KF, Cavanaugh JE, Dwoskin LP, Melchert RB, Nemire RE, O’Donnell JM, Priefer R, Touchette D. Competency, Programming, and Emerging Innovation in Graduate Education within Schools of Pharmacy: The Report of the 2016-2017 Research and Graduate Affairs Committee.. American journal of pharmaceutical education. 2017;81(8):S11. doi:10.5688/ajpeS11.

  • Kim K, Lee TA, Ardati AK, DiDomenico RJ, Touchette D, Walton SM. Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome.. Pharmacotherapy. 2017;37(8):877-887. doi:10.1002/phar.1961.

  • Kim K, DiDomenico RJ, Touchette D, Walton SM. Letter–The Authors Respond.. Journal of managed care & specialty pharmacy. 2017;23(5):599-600. doi:10.18553/jmcp.2017.23.5.599.

  • Xing S, Sharp L, Touchette D. Weight loss drugs and lifestyle modification: Perceptions among a diverse adult sample.. Patient education and counseling. 2017;100(3):592-597. doi:10.1016/j.pec.2016.11.004.

  • Kim K, Lee TA, Touchette D, DiDomenico RJ, Ardati AK, Walton SM. Contemporary Trends in Oral Antiplatelet Agent Use in Patients Treated with Percutaneous Coronary Intervention for Acute Coronary Syndrome.. Journal of managed care & specialty pharmacy. 2017;23(1):57-63. doi:10.18553/jmcp.2017.23.1.57.

  • Billups SJ, Olson KL, Saseen JJ, Irwin AN, Touchette D, Chennault RR, Kurz D. Evaluation of the Effect of A Structured Program to Guide Residents’ Experience in Research (ASPIRE) on Pharmacy Residents’ Knowledge, Confidence, and Attitude toward Research.. Pharmacotherapy. 2016;36(6):631-7. doi:10.1002/phar.1765.

  • Syed ST, Sharp L, Kim Y, Jentleson A, Lora CM, Touchette D, Berbaum ML, Suda K, Gerber BS. Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus.. Pharmacotherapy. 2016;36(6):590-7. doi:10.1002/phar.1757.

  • Kim K, Lee TA, Ardati AK, DiDomenico RJ, Touchette D, Walton SM. Comparative Effectiveness of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndrome.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2015;18(7):A376. doi:10.1016/j.jval.2015.09.784.

  • Touchette D, Doloresco F, Suda K, Perez A, Turner S, Jalundhwala Y, Tangonan MC, Hoffman JM. Economic evaluations of clinical pharmacy services: 2006-2010.. Pharmacotherapy. 2014;34(8):771-93. doi:10.1002/phar.1414.

  • Patel V, Lin FJ, Ojo O, Rao S, Yu S, Zhan L, Touchette D. Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention.. Pharmacy practice. 2014;12(3):438.

  • Samp JC, Touchette D, Marinac JS, Kuo GM. Economic evaluation of the impact of medication errors reported by U.S. clinical pharmacists.. Pharmacotherapy. 2014;34(4):350-7. doi:10.1002/phar.1370.

  • Lora CM, Sokolovsky AW, Touchette D, Jin J, Hu X, Gao W, Gerber BS. ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes.. Ethnicity & disease. 2013;23(2):189-95.

  • Kuo GM, Touchette D, Marinac JS. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.. Pharmacotherapy. 2013;33(3):253-65. doi:10.1002/phar.1195.

  • Gerber BS, Rapacki L, Castillo A, Tilton JJ, Touchette D, Mihailescu D, Berbaum ML, Sharp L. Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes.. BMC public health. 2012;12:891. doi:10.1186/1471-2458-12-891.

  • Touchette D, Rao S, Dhru PK, Zhao W, Choi YK, Bhandari I, Stettin GD. Identification of and intervention to address therapeutic gaps in care.. The American journal of managed care. 2012;18(10):e364-71.

  • Touchette D, Masica AL, Dolor RJ, Schumock GT, Choi YK, Kim Y, Smith SR. Safety-focused medication therapy management: a randomized controlled trial.. Journal of the American Pharmacists Association : JAPhA. 2012;52(5):603-12. doi:10.1331/JAPhA.2012.12036.

  • Dolor RJ, Masica AL, Touchette D, Smith SR, Schumock GT. Patient safety-focused medication therapy management: challenges affecting future implementation.. The American journal of managed care. 2012;18(7):e238-44.

  • Touchette D, Yang Y, Tiryaki F, Galanter WL. Economic analysis of alvimopan for prevention and management of postoperative ileus.. Pharmacotherapy. 2012;32(2):120-8. doi:10.1002/PHAR.1047.

  • Schiff GD, Galanter WL, Duhig J, Koronkowski MJ, Lodolce AE, Pontikes P, Busker JF, Touchette D, Walton SM, Lambert BL. A prescription for improving drug formulary decision making.. PLoS medicine. 2012;9(5):1-7. doi:10.1371/journal.pmed.1001220.

  • Lau DT, Briesacher BA, Touchette D, Stubbings J, Ng JH. Medicare Part D and quality of prescription medication use in older adults.. Drugs & aging. 2011;28(10):797-807. doi:10.2165/11595250-000000000-00000.

  • Perez A, Touchette D, DiDomenico RJ, Stamos TD, Walton SM. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.. Pharmacotherapy. 2011;31(6):552-65. doi:10.1592/phco.31.6.552.

  • Touchette D. (2010). Improving adherence in the community and clinic pharmacy settings: an emerging opportunity.. Pharmacotherapy. Vol. 30. Issue 5. Page(s) 425-7.

  • Hoffman JM, Meek PD, Touchette D, Vermeulen LC, Schumock GT. (2009). Transparent and reproducible reports of economic evaluations of clinical pharmacy services: a goal for the future?. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. Vol. 66. Issue 5. Page(s) 442-3; author reply 443-4.

  • Hartung DM, Touchette D. Overview of clinical research design.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2009;66(4):398-408. doi:10.2146/ajhp080300.

  • Perez A, Doloresco F, Hoffman JM, Meek PD, Touchette D, Vermeulen LC, Schumock GT. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.. Pharmacotherapy. 2009;29(1):128. doi:10.1592/phco.29.1.128.

  • Pellegrino AN, Martin M, Tilton JJ, Touchette D. Medication therapy management services: definitions and outcomes.. Drugs. 2009;69(4):393-406. doi:10.2165/00003495-200969040-00001.

  • Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, Touchette D. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension.. Journal of general internal medicine. 2008;23(12):1966-72. doi:10.1007/s11606-008-0791-x.

  • Masica AL, Touchette D, Dolor RJ, Schumock GT, Kliethermes MA, Rodgers PT, Craft JL, Choi YK, Lux LJ, Smith SR. (2008). Evaluation of a Medication Therapy Management Program in Medicare Beneficiaries at High Risk of Adverse Drug Events: Study Methods. Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 4: Technology and Medication Safety). Agency for Healthcare Research and Quality (US).

  • Kim S, Touchette D, Stubbings J, Schullo-Feulner AM, Pater KS. Pilot assessment of patient satisfaction and clinical impact of Medicare Part D in diabetic geriatric patients.. Pharmacy practice. 2008;6(3):128-35.

  • Touchette D, Bearden DT, Ottum SA. Research publication by pharmacist authors in major medical journals: changes over a 10-year interval.. Pharmacotherapy. 2008;28(5):584-90. doi:10.1592/phco.28.5.584.

  • Ng TM, Bell AM, Hong C, Hara JM, Touchette D, Danskey KN, Lindsay TT, Puumala SE. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.. The Annals of pharmacotherapy. 2008;42(4):475-82. doi:10.1345/aph.1K458.

  • Touchette D, Mcguinness ME, Stoner S, Shute D, Edwards JM, Ketchum K. Improving outpatient warfarin use for hospitalized patients with atrial fibrillation.. Pharmacy practice. 2008;6(1):43-50.

  • Touchette D, Masica AL. (2007). Evidence needed for policy decisions: adherence interventions and Medicare Part D.. Archives of internal medicine. Vol. 167. Issue 17. Page(s) 1905.

  • Touchette D, Burns AL, Bough MA, Blackburn JC. Survey of medication therapy management programs under Medicare part D.. Journal of the American Pharmacists Association : JAPhA. 2006;46(6):683-91.

  • Fagan SC, Touchette D, Smith JA, Sowinski KM, Dolovich L, Olson KL, Cheang KI, Kolesar JM, Crismon ML. The state of science and research in clinical pharmacy.. Pharmacotherapy. 2006;26(7):1027-40. doi:10.1592/phco.26.7.1027.

  • Hartung DM, Touchette D, Bultemeier NC, Haxby DG. Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.. Pharmacotherapy. 2005;25(10):1329-36. doi:10.1592/phco.2005.25.10.1329.

  • Hartung DM, Hunt J, Siemienczuk J, Miller H, Touchette D. Clinical implications of an accurate problem list on heart failure treatment.. Journal of general internal medicine. 2005;20(2):143-7. doi:10.1111/j.1525-1497.2005.40206.x.

  • Hartung DM, Touchette D, Ketchum KL, Haxby DG, Goldberg BW. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population.. Clinical therapeutics. 2004;26(9):1518-32. doi:10.1016/j.clinthera.2004.09.013.

  • Hunt JS, Siemienczuk J, Touchette D, Payne N. Impact of educational mailing on the blood pressure of primary care patients with mild hypertension.. Journal of general internal medicine. 2004;19(9):925-30. doi:10.1111/j.1525-1497.2004.40046.x.

  • Rudis MI, Touchette D, Swadron SP, Chiu AP, Orlinsky M. Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department.. Annals of emergency medicine. 2004;43(3):386-97. doi:10.1016/S0196064403010680.

  • Fuke D, Hunt J, Siemienczuk J, Estoup M, Carroll M, Payne N, Touchette D. Cholesterol management of patients with diabetes in a primary care practice-based research network.. The American journal of managed care. 2004;10(2 Pt 2):130-6.

  • Onofrei M, Hunt J, Siemienczuk J, Touchette D, Middleton B. A first step towards translating evidence into practice: heart failure in a community practice-based research network.. Informatics in primary care. 2004;12(3):139-45.

  • Touchette D, Durgin TL, Wanke LA, Goodkin DE. A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-1b in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis.. Clinical therapeutics. 2003;25(2):611-34.

  • Du W, Touchette D, Vaitkevicius VK, Peters WP, Shields AF. Cost analysis of pancreatic carcinoma treatment.. Cancer. 2000;89(9):1917-24.

  • Touchette D, Rhoney DH. Cost-minimization analysis of phenytoin and fosphenytoin in the emergency department.. Pharmacotherapy. 2000;20(8):908-16.

    • Education

  • MA, Economics, Wayne State University Detroit, MI

  • Fellowship in Pharmacoeconomic and Outcomes Research, Fellowship in Pharmacoeconomic and Outcomes Research, Wayne State University Detroit, MI

  • PharmD, Wayne State University Detroit, MI

  • BS, University of Manitoba Winnipeg, Manitoba